The effect of sulphinpyrazone on the aggregation and release reactions of human platelets.
D000118:Acetylglucosaminidase / Q000378:metabolism; D000818:Animals; D001792:Blood Platelets / Q000502:physiology*; D002417:Cattle; D002463:Cell Membrane Permeability / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010978:Platelet Factor 4 / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D012310:Ristocetin / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013442:Sulfinpyrazone / Q000494:pharmacology*
D012310:Ristocetin; D012701:Serotonin; D010978:Platelet Factor 4; D003094:Collagen; D000118:Acetylglucosaminidase; D011188:Potassium; D013442:Sulfinpyrazone; D004837:Epinephrine